Axonics Announces FDA Approval Of Enhanced Neurostimulator Programmer
Axonics Modulation Technologies, Inc. (NASDAQ:AXNX), a medical technology company that has developed and is commercializing novel implantable rechargeable…
EC Approves Roche’s Polivy for People with Previously Treated Aggressive Lymphoma
Roche (OTC:RHHBY) today announced that the European Commission has granted conditional marketing authorisation for Polivy® (polatuzumab vedotin), in…
Novartis Announces EU Approval of Mayzent for Adult Patients with Secondary Progressive MS with Active Disease
Novartis (NYSE:NVS) today announced the European Commission (EC) has approved Mayzent® (siponimod) for the treatment of adult patients…
Jazz Pharmaceuticals Receives EU Marketing Authorisation for Sunosi for Excessive Daytime Sleepiness in Adults with Narcolepsy or Obstructive Sleep Apnea
Jazz Pharmaceuticals plc (NASDAQ:JAZZ) today announced that the European Commission approved Sunosi® (solriamfetol) to improve wakefulness and reduce…
Genmab Announces EU Marketing Authorization for DARZALEX in Combination with Bortezomib, Thalidomide and Dexamethasone in Frontline Multiple Myeloma
Genmab A/S (NASDAQ:GMAB) announced today that the European Commission (EC) has granted marketing authorization for DARZALEX® (daratumumab) in…
7 Blockbuster Drugs Expected To Be Launched In 2020
Biotech stocks had a fairly decent run in 2019, thanks to record deal flow, several path-breaking innovation in…
The Week Ahead In Biotech: Focus On Epizyme, Merck Ahead Of PDUFA Dates, J&J To Kickstart Big Pharma Earnings
Biotech news flow remained light last week, although there were some notable developments such as FDA panel reviews…
A Look at Some ‘Legit’ OTC Stocks
Many investors are leery of OTC, or over-the-counter, stocks – and there are plenty of good reasons for that caution. OTC stocks often involve companies too small to be listed and traded on the coventional and better-known stock exchanges.